Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy characterized by the accumulation of incompletely differentiated progenitor cells (blasts) in the bone marrow and blood, and by suppression of normal hematopoiesis. It has recently become apparent that the AML genome is charact...
Main Authors: | Daniela Magliulo, Rosa Bernardi, Samantha Messina |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00255/full |
Similar Items
-
Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1
by: Jiajun Zhou, et al.
Published: (2021-12-01) -
Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases
by: Hideaki Niwa, et al.
Published: (2017-05-01) -
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
by: Barbara Majello, et al.
Published: (2019-03-01) -
Lysine specific demethylase 1 is a molecular driver and therapeutic target in sarcoma
by: Rachel D. Dreher, et al.
Published: (2023-01-01) -
LSD1 inhibitors disrupt the GFI1 transcription repressor complex
by: Alba Maiques-Diaz, et al.
Published: (2018-07-01)